IDEX (IEX) CFO receives new stock options and restricted share awards

Rhea-AI Filing Summary

Gillen Sean M. reported acquisition or exercise transactions in this Form 4 filing.

IDEX CORP reported that its SVP and Chief Financial Officer, Sean M. Gillen, received new equity awards. He was granted 10,160 options to buy common stock and 2,410 restricted shares on February 19, 2026. The restricted shares vest in three substantially equal annual installments beginning February 19, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to his continuous employment. These awards increase his direct equity stake in the company and are designed to align his compensation with long-term company performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gillen Sean M.

(Last) (First) (Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	02/19/2026		A		2,410(1)	A	$0	19,005	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OPTIONS (RIGHT TO BUY)	$207.86	02/19/2026		A		10,160		(2)	02/19/2036	COMMON STOCK	10,160	$0	10,160	D

Explanation of Responses:

1. Represents an award of restricted shares, which vest in three substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.

2. This option will vest in four substantially equal annual installments beginning February 19, 2027, subject to the Reporting Person's continuous service through each such date.

	/s/ Sam Rayburn, by Power of Attorney	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IDEX (IEX) CFO Sean M. Gillen report on this Form 4?

Sean M. Gillen reported equity awards from IDEX, not open-market trades. He received 10,160 stock options and 2,410 restricted shares, both granted on February 19, 2026, as part of his executive compensation package.

How many stock options did the IDEX (IEX) CFO receive?

The CFO received 10,160 options to buy IDEX common stock. These options vest in four substantially equal annual installments beginning February 19, 2027, and each installment is contingent on his continuous service with the company through the applicable vesting date.

What restricted stock did the IDEX (IEX) CFO acquire in this filing?

He acquired an award of 2,410 restricted shares of IDEX common stock. These restricted shares vest in three substantially equal annual installments starting February 19, 2027, provided he remains continuously employed through each scheduled vesting date.

Are the IDEX (IEX) equity awards to the CFO immediately vested?

No, the awards are time-vested. The restricted shares vest over three years, while the stock options vest over four years, with vesting beginning on February 19, 2027, subject to Sean M. Gillen’s continuous service at IDEX.

Did the IDEX (IEX) CFO buy or sell shares in the open market?

No open-market buys or sells are reported. The Form 4 shows grant or award acquisitions of options and restricted stock at a reported price of $0.00 per share, reflecting compensatory awards rather than market transactions.

How many IDEX (IEX) common shares does the CFO hold after this award?

After the restricted stock award, Sean M. Gillen directly holds 19,005 shares of IDEX common stock. This figure reflects his direct ownership position reported in the filing following the February 19, 2026 compensatory grant.